Infervision, a Chinese startup that offers artificial intelligence (AI)-based medical imaging solutions, has closed a new investment that brings the firm’s total capital raise in its Series D round to nearly 900 million yuan ($139 million).
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in